||Anthony L. Asher, MD, FAANS, FACS
||Carolina Neurosurgery & Spine Assoc., 225 Baldwin Ave, Charlotte, NC 28204-3109
||United States of America
Anthony L. Asher, MD, FAANS, FACS is President, Atrium Health Neuroscience Institute and is Neurological Surgery Residency Program Director at Carolinas Medical Center. He is also Clinical Professor in Neurosurgery at the University of North Carolina Chapel Hill, Carolinas Medical Center, and Vanderbilt University School of Medicine.
Dr. Asher attended Wayne State University School of Medicine, where he was awarded one of the original Howard Hughes Medical Institute Research Scholarships. Dr Asher completed his neurosurgery residency training at the University of Michigan Hospitals and also served as a Staff Fellow in the Surgery Branch of the National Cancer Institute, NIH.
Since the completion of his residency training and fellowship, Dr. Asher has been a member of the Charlotte, NC based Carolina Neurosurgery and Spine Associates, where his primary practice interests include neuro-oncology, skull-base surgery, minimally invasive spine surgery, stereotactic surgery, and trigeminal neuralgia. Dr. Asher has been recognized yearly as one of the Best Doctors in America since 2003. He has also been recognized as one of the nation’s Top Doctors for Cancer Care.
Dr. Asher has wide-ranging medical research experience, and has established cooperative cancer and spine investigative programs with clinical and laboratory scientists at community and academic institutions across the country. Dr. Asher is the author or co-author of over 130 peer-reviewed manuscripts along with numerous abstracts and book chapters.
Dr. Asher founded and is Surgical Director of the multi-disciplinary Adult Brain Tumor Program at Atrium Health’s Levine Cancer Institute. He is co-founder of the Brain Tumor Fund for the Carolinas (BTFC) and served as Chairman of the BTFC from 2003-2014. He is Past Chairman and Co-Founder, Charlotte Brain Tumor Support Group and developer of the NeuroOncology Nurse Navigator Program at Carolinas Medical center. Dr. Asher’s basic oncology research has focused on tumor immunobiology. His clinical research has focused on novel therapies for primary and secondary CNS malignancies. He is a Radiation Therapy Oncology Group (RTOG) principal investigator and a member of that organization’s Brain Tumor Committee.
Dr. Asher’s most recent neurooncology investigations have focused on novel radiation treatments for cerebral metastases. He was Co-developer and Co-principal investigator (RTOG PI) of NCCTG-574: “A Phase III Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in the Management of Patients with One to Three Cerebral Metastases”, a multi-institutional, cooperative NCI Trial administered through the North Central Cancer Treatment Group and Radiation Therapy Oncology Group. This ten year, multi-institutional, international trial established SRS alone as the standard of care for patient with newly diagnosed oligo cerebral metastases. He is Co-developer of a novel treatment paradigm: neoadjuvant radiosurgery prior to surgical resection of brain metastases, and is Co-Principal Investigator: “A Randomized Phase II Trial of Pre-Operative Compared to Post-Operative Stereotactic Radiosurgery (SRS) in Patients with Resected Brain Metastases” (RTOG submission to CTEP (NCI)). He is Alliance co-chairman (neurosurgical lead) for: Phase III Trial of Stereotactic Radiosurgery compared with Whole Brain Radiotherapy (WBRT) for 5-15 Brain Metastases (CCTG CE.7).
Dr. Asher holds or has held senior leadership roles and memberships in several key medical professional organizations. He was named treasurer of the American Association of Neurological Surgeons (AANS) during the 87th AANS Annual Scientific Meeting, held in San Diego, Calif., April 13-17, 2019. He is a member of the Congress of Neurological Surgeons (CNS; President 2007–2008), the American Medical Association (AMA; Advisory Committee, National Quality Registry Network), and the Southern Neurosurgical Society. He is a past Director and Vice-Chairman of the American Board of Neurological Surgery (ABNS). He is founder and former Chairman of the AANS/CNS Academic-Community Brain Tumor Alliance and was a member of the AANS/CNS Section on Tumors Executive Committee for over a decade. He is also a member of the Joint Section on Disorders of Spine and Peripheral Nerves. Dr. Asher is a Fellow of the American College of Surgeons (ACS) and a past Chairman of the Brain Organ Site Group of the ACS Oncology Group. He has been elected to the American Academy of Neurological Surgery and the Society of Neurological Surgeons.
Dr. Asher has extensive leadership experience in quality improvement. While CNS President, he developed and Co-Chaired the AANS-CNS Data and Quality Task Force, which ultimately led to the creation of many of the current national neurosurgery cooperative data programs. He co-founded and is recent past Vice Chairman of the AANS NeuroPoint Alliance (NPA), a 501(c)(6) which coordinates numerous national quality science, quality improvement and research projects for neurosurgery and related specialties. He co-founded, and is presently Director of the Quality and Outcomes Database (QOD), an unprecedented cooperative clinical registry, with over 140,000 patients to date in 110 clinical centers nationally. He co-founded and serves as Co-Chairman of the American Spine Registry (ASR), a novel cooperative clinical database jointly administered by the AANS and American Academy of Orthopedic Surgery (AAOS). He co-developed the NPA-Qualified Clinical Data Registry (QCDR), neurosurgery’s first specialty-specific public quality measure set. He is past Co-Chairman, AANS/CNS National Quality Council. Dr. Asher is past Chairman of the ABNS Data and Quality Improvement Committee and was principal developer of the ABNS Practice and Outcomes of Surgical Therapies (POST) project (a comprehensive outcomes registry designed to facilitate ABNS initial certification and maintenance of certification (MOC)